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Phospholipids are asymmetrically distributed in the plasma membrane. This asymmetrical 
distribution is disrupted during apoptosis, exposing phosphatidylserine (PtdSer) on the cell 
surface. Here, using a haploid genetic screen we found that ATP11C (ATPase, type 11C) and 
CDC50A (Cell division cycle protein 50A) are required for aminophospholipid translocation 
from the outer to inner plasma-membrane leaflet (flippase activity). ATP11C contained caspase-
recognition sites, and mutations at these sites generated caspase-resistant ATP11C without 
affecting its flippase activity. Cells expressing caspase-resistant ATP11C did not expose PtdSer 
during apoptosis, and were not engulfed by macrophages, suggesting that inactivation of the 
flippase activity is required for apoptotic PtdSer exposure. CDC50A-deficient cells displayed 
PtdSer on their surface, and were engulfed by macrophages, indicating that PtdSer is sufficient as 
an “eat me” signal.  
 
One Sentence Summary: Identification of a caspase-regulated flippase for the asymmetrical 
distribution of phospholipids in the plasma membrane. 
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In eukaryotic cells, phospholipids are asymmetrically distributed between the outer and 
inner leaflets of the plasma membrane (1). Phosphatidylcholine [PtdCho] and sphingomyelin are 
located primarily in the outer leaflet, while phosphatidylserine [PtdSer], and phosphatidyl-
ethanolamine [PtdEtn] are restricted to the cytoplasmic leaflet. Disruption of asymmetrical 
phospholipid distribution, in particular, cell-surface PtdSer exposure, is important in various 
biological processes. For example, platelet activation leads to PtdSer exposure to activate 
clotting factors (1), and apoptotic cells expose PtdSer to be engulfed by phagocytes (2). 
Scramblases non-specifically transport phospholipids bidirectionally (1). TMEM16F is essential 
for PtdSer-exposure in activated platelets (3), while Xkr8 (XK-related protein 8) supports the 
phospholipid scrambling after being cleaved by caspase during apoptosis (4). Flippases transport 
aminophospholipids from the extracellular to cytoplasmic side (1). Some members (mammalian 
ATP8A1 and its orthologs in yeast and C. elegans, and ATP11C) of the Type 4 subfamily of P-
type ATPases (P4-ATPase) have been proposed to act as flippases (5-8). Earlier studies reported 
that the flippase is inactivated during apoptosis (9, 10), but, its identity and how it is inactivated 
is unclear.  
We used a haploid genetic screen in human KBM7 cells (11) to identify the plasma 
membrane PtdSer flippase. KBM7 cells incorporated 1-oleoyl-2-{6-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-PtdSer (NBD-PS), NBD-PtdEtn (NBD-PE) 
and NBD-PtdCho (NBD-PC) with different efficiencies (Fig. 1A). KBM7 cells were 
mutagenized with a gene trap vector. Approximately 1.0% of the cells defective in NBD-PS 
internalization were expanded, and subjected to a second sorting step to obtain “Low Flipping” 
cells (LF)(Fig. 1B). Gene-trap insertion sites were recovered by polymerase chain reaction from 
LF cells, and identified by deep sequencing (12). Proximity index, for genomic regions 
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containing multiple insertions in close proximity, identified two genes (CDC50A, Cell division 
cycle protein 50A, and ATP11C, ATPase type 11C) (Fig. 1B). Based on the information from 
genome database (http://genome.ucsc.edu/cgi-bin/hgTracks?org=human) and 5’-RACE (Rapid 
amplification of cDNA end) analysis (fig. S1), most of the insertions were assigned to intron 1 in 
the transcriptional direction (Fig. 1C).     
 ATP11C is a member of P4-ATPase family, and CDC50A is its β-subunit (Fig. S2A) (13, 
14). They were expressed in various tissues (Fig. S2B). Cloned cell lines (ATP11CGT and 
CDC50AGT) that lost the expression of ATP11C or CDC50A (Fig. S2C) were isolated. The 
ability to incorporate NBD-PS and NBD-PE, but not NBD-PC was reduced in ATP11CGT and 
the transformation with human (h)ATP11C rescued it (Fig. 1D). The incorporation of 
phospholipids in ATP11CGT was inhibited by orthovanadate (Fig. 1E), suggesting that the 
remaining flippase activity was due to other P4-ATPases in KBM7 cells (Fig. S2D). Among 
three members, only CDC50A was expressed in KBM7 cells (Fig. S2D), and the internalization 
of NBD-PS was completely defective in CDC50AGT, which was rescued with hCDC50A (Fig. 
1D). CDC50AGT, but not ATP11CGT exposed PdtSer on the cell surface (Fig. 1F), suggesting 
that the residual PtdSer-flippase in ATP11CGT was sufficient to maintain the asymmetrical 
PtdSer distribution. The ability to internalize NBD-PC was also reduced in CDC50AGT (Fig. 1D), 
indicating that some P4-ATPases in KBM7 cells may promote PtdCho flipping.  
To study the effect of the PtdSer-flippase on apoptotic PtdSer, we chose W3 cells that 
undergo apoptosis upon treatment with Fas ligand (FasL)(15). W3 cells expressed several P4-
ATPases (fig. S3A), and incorporated NBD-PS, NBD-PE and NBD-PC with different 
efficiencies (fig. S3B). ATP11C in W3 cells was mutated using the CRISPR/Cas (clustered 
regulatory interspaced short palindromic repeats/CRISPR associated) system (16)  (fig. S3C). 
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Two cloned cell lines (ATP11CED22 and ATP11CED23) carrying biallelic ATP11C truncations lost 
the ability to internalize NBD-PS and NBD-PE (Fig. 2A and fig. S3D). Apoptotic PtdSer 
exposure is accompanied by the loss of PtdSer-flippase activity (9, 10). Treating W3 cells with 
FasL reduced ATP11C from 120 to 50 kDa (Fig. 2B), which was prevented by a caspase 
inhibitor (Q-VD-OPh). A search using Cascleave (http://sunflower.kuicr.kyoto-
u.ac.jp/~sjn/Cascleave/) revealed three caspase-recognition sequences (Sites 1-3) in the 
Nucleotide-binding or “N” domain of hATP11C (fig. S4A). Mutants in Sites 1-3 were generated 
(fig. S4B), tagged by Green fluorescent protein (GFP) at the C-terminus, and expressed in 
ATP11CED22. The transformants were treated with FasL, and analyzed by immunoblotting with 
anti-GFP antibodies (Fig. 2C). The FasL-treatment caused a shift of the wild-type and doubly 
mutated hATP11C-GFP from 140 to 80 kDa. While, little cleavage was observed with the triply 
mutated hATP11C-GFP (CasR). Incubation of the membrane fraction carrying hATP11C-GFP 
with caspases revealed that hATP11C was cleaved by caspase-3, -6 and -7 (fig. S5). ATP11CED22 
expressing CasR (ATP11CED22-CasR) incorporated NBD-PS as efficiently as those expressing 
wild-type ATP11C (ATP11CED22-hATP11C) (Fig. 2D), and could not expose PtdSer upon FasL-
treatment (Fig. 2E), although caspase-3 was activated (Fig. 2E). Transformation of W3-Ildm 
cells, a derivative of W3 cells (17), and human Jurkat cells with CasR, but not with wild-type 
hATP11C blocked the FasL-induced PtdSer-exposure (fig. S6). CasR had no effect on the FasL-
induced scramblase, measured by NBD-PC incorporation (Fig. 2F). FasL-induced cell death, cell 
shrinkage and DNA fragmentation were also normal in CasR-expressing cells (fig. S7). The 
FasL-treated W3-Ildm cells and the hATP11C-transformants were efficiently engulfed by 
thioglycollate-elicited peritoneal macrophages (thio-pMacs), while the CasR-transformants were 
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not (Fig. 2G), suggesting that the flippase must be inactivated by caspase for engulfment of 
apoptotic cells. 
CDC50A was then mutated using the Crispr/Cas system in W3-Ildm cells that expressed 
only CDC50A in the CDC50 family (fig. S8A). Cloned cell lines (CDC50AED29 and 
CDC50AED62) carrying a biallelic truncation (fig. S8B) could not support the localization of 
hATP11C-GFP at the plasma membrane (Fig. 3A), could not internalize NBD-PS (Fig. 3B), and 
exposed PtdSer (Fig. 3C and fig. S9A). Transformation of CDC50AED cells with hCDC50A 
supported the localization of ATP11C at the plasma membrane, rescued the flippase activity, and 
blocked PtdSer exposure, confirming the chaperone-like function of CDC50 for P4-ATPase (5, 
13, 14). W3 cells expressing a constitutively active form of TMEM16F (D430G-L) (3, 18) 
internalized NBD-PS (Fig. 3B), bound MFG-E8, a PtdSer-binding protein (19), in HEPES 
buffered saline containing 2.5 mM CaCl2, but not in Iscove’s modified Dulbecco’s medium 
(IMDM)-10% fetal calf serum (FCS) (Fig. 3D). In contrast, CDC50AED cells bound MFG-E8 in 
IMDM-10% FCS. Observation by microscope confirmed the binding of MFG-E8 to CDC50AED 
cells. The doubling time of CDC50AED29 cells was slightly longer than W3-Ildm cells (12.2 + 
0.39 vs. 13.7 + 0.14 h) (fig. S9B), but CDC50AED29 cells responded normally to FasL for 
apoptosis (fig. S9C).  
When living CDC50AED cells were cultured with thio-pMacs in medium containing 1.0% 
methylcellulose, more than 20% of the macrophages engulfed CDC50AED cells (Fig. 4A). The 
thio-pMacs did not engulf W3-Ildm cells, W3-D430G-L cells, or CDC50AED-hCDC50A cells. 
The engulfment of CDC50AED cells was inhibited by D89E, which masks PtdSer (19). Similar to 
the engulfment of apoptotic cells (20), living CDC50AED cells were not engulfed by MerTK-/- 
thio-pMacs (Fig. 4B). Among 132 events of engulfment (Fig. 4C and Movie S1-S2), 
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approximately 80% events were with living cell, while 20% were apoptotic cells. As reported for 
the entosis of epithelial cells (21), the engulfment of living CDC50AED cells was reversible until 
a certain point. Approximately 3% of the engulfed cells were released from the macrophages 
before they were transferred into lysosomes (Fig. 4D and Movie S3). The release of engulfed 
cells was not observed with caspase-positive cells. Examination with electron microscopy 
showed that the engulfed living cells had a swollen morphology (Fig. 4E), different from the 
apoptotic cells with a condensed morphology. Engulfment of living PtdSer-exposing cells by 
thio-pMacs was also observed with CDC50A-null KBM7 cells (fig. S10). Subcutaneous 
transplantation of W3-Ildm cells into nude mice induced tumors in 8 of 11 recipients, and the 
tumor size was approximately 4.3 g after 4 weeks (Fig. 4F). CDC50AED, but not its hCDC50A-
transformants, lost the ability to develop tumors, suggesting that CDC50AED was cleared in vivo.    
Here we have shown that ATP11C can function as a PtdSer-flippase at the plasma 
membrane. ATP11C-deficient KBM7 cells and W3 cells exhibited reduced PtdSer-flippase 
activity, while CDC50A-null cells almost completely lost the activity. Most, if not all, P4-
ATPases require CDC50 family proteins as a functional subunit or chaperone (5, 22, 23). KBM7 
cells and W3 cells expressed only CDC50A among CDC50 proteins, but expressed ATP11C and 
other P4-ATPases, some of which may also function as a PtdSer-flippase. PtdSer-flippase has 
been considered to be specific for aminophospholipids (14). But, as reported previously with 
Jurkat cells (24), CDC50A-null KBM7 cells lost the ability to transport PtdCho, suggesting that 
some P4-ATPases may flip PtdCho. In apoptosis, Xkr8’s scramblase is activated (4) and 
ATP11C’s flippase is inactivated to expose PtdSer. The PtdSer exposure in activated platelets 
and lymphocytes is Ca2+-dependent (3, 25). Because a high Ca2+ concentration inhibits P4-
ATPases (26), PtdSer exposure in these processes may be mediated by the Ca2+-dependent 
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activation of scramblases coupled to the Ca2+-mediated down-regulation of flippase activity. 
Once cellular Ca2+ levels are reduced, ATP11C and/or other P4-ATPases would re-establish the 
asymmetric phospholipid distribution in the plasma membrane. On the other hand, caspase-
mediated apoptotic PtdSer exposure is irreversible, leading to engulfment by macrophages.  
The engulfment of living cells by neighboring cells or macrophages has been reported in 
various systems (21, 27, 28). Our results, the engulfment of PtdSer-exposing CDC50A-null cells 
by macrophages, support the idea (28) that when PtdSer is exposed, even viable cells can be 
engulfed. The engulfment of living cells may be involved in various diseases, such as 
hemophagocytosis, neurodegeneration, and cancer (29). ATP11C-defective mice lose a large 
number of B cells during Pro to Pre-B cell differentiation in bone marrow (7, 30), and a weak 
defect in the PtdSer internalization has been detected in Pro-B cells (7). One possible explanation 
is that among the P4-ATPases promoting flippase activity, only ATP11C is expressed in the 
early stage of B cell development. Thus, ATP11C-defective cells expose PtdSer and are engulfed 
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Fig. 1. Screening for phospholipid flippase. (A) KBM7 cells were incubated with 1.5 µM NBD-
phospholipids, treated with bovine serum albumin (BSA), and analyzed by Fluorescence 
activated cell sorting (FACS). Mean fluorescence intensity (MFI) plotted. (B) Mutagenized 
KBM7 cells that incorporated low levels (~1%) of NBD-PS were collected, and sorted to 
generate low flipping (LF) cells. (C) Identification of gene-trap insertions. Proximity index 
plotted for human chromosome with number (N) of insertions. Arrows, insertion positions for 
sense (red) and antisense-orientation (green). (D) Incorporation of NBD-phospholipids into 
KBM7, ATP11CGT, ATP11CGT-hATP11C, CDC50AGT, or CDC50AGT-hCDC50A cells, 
expressed as ratio of that with KBM7 cells (n=3). (E) Effect of vanadate on the NBD-PS 
incorporation into KBM7, ATP11CGT, and CDC50AGT cells, expressed as ratio of that with 
KBM7 cells in the absence of vanadate (n=3). (F) Annexin V-staining profile of KBM7, 
ATP11CGT, CDC50AGT, and CDC50AGT-hCDC50A cells with percentage of Annexin V-positive 
cells.  
 
Fig. 2. Cleavage of ATP11C during apoptosis. (A) Incorporation of NBD-PS into W3, 
ATP11CED22, ATP11CED23, ATP11CED22-hATP11C, and ATP11CED23-hATP11C cells, expressed 
as ratio of that with W3 cells (n=3). (B) W3 and ATP11CED22 cells were incubated for 1 h with 
FasL in the presence or absence of 20 µM QVD-OPh. Membrane fractions were analyzed by 
immunoblotting with anti-mATP11C or anti-Fas antibodies (Abs). Middle panel, longer 
exposure. (C) ATP11CED22, ATP11CED22-hATP11C-GFP, or ATP11CED22-mutant hATP11C-
GFP cells were incubated for 45 min with FasL, and analyzed by immunoblotting with anti-GFP 
Abs. (D) W3, ATP11CED22, ATP11CED22-hATP11C, and ATP11CED22-CasR cells were incubated 
with NBD-PS, treated with BSA, and analyzed by FACS. MFI plotted (n=3). (E) Annexin V-
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staining profile of W3, ATP11CED22, ATP11CED22-hATP11C, and ATP11CED22-CasR cells, that 
were untreated (red) or FasL-treated for 2 h (blue). On right, immunoblotting of the cell lysates 
with anti-cleaved caspase 3. (F) W3, ATP11CED22, ATP11CED22-hATP11C, and ATP11CED22-
CasR cells were treated for 1 or 2 h with FasL, incubated with 0.5 µM NBD-PC for 4 min, and 
analyzed by FACS. MFI plotted (n=3). (G) W3-Ildm, W3Ildm-hATP11C, and W3Ildm-CasR 
cells were treated with FasL, labeled with pHrodo, incubated for 1 h with thio-pMacs, and 
analyzed by FACS.  
 
Fig. 3. PtdSer exposure in CDC50A-/- cells. (A) Observation of hATP11C-GFP expressed in 
CDC50AED29 or CDC50AED29-hCDC50A cells by confocal fluorescence microscopy. DIC, 
differential interference contrast. Scale bar, 5 µm. (B) Incorporation of NBD-PS into W3-Ildm, 
CDC50AED29, CDC50AED62, CDC50AED29-hCDC50A, CDC50AED62-hCDC50A, and W3-
D430G-L cells, expressed as ratio of that with W3-Ildm cells (n=3). (C) W3-Ildm, CDC50AED29, 
CDC50AED62 cells, and their hCDC50A-transformants (red) were stained with Cy5-Annexin V or 
FITC-MFG-E8 in Annexin V-buffer. (D) W3-Ildm, CDC50AED29, and W3-D430G-L cells were 
incubated at room temperature for 5 min with FITC-MFG-E8 in HEPES buffered saline or in 
IMDM-10% FCS. MFI is indicated (n=3). In lower panels, W3-Ildm, CDC50AED29, and 
CDC50AED62 cells were stained with FITC-MFG-E8 in IMDM-10% FCS, and observed by 
confocal fluorescence microscopy. Scale bar, 10 µm. 
Fig. 4. Engulfment of viable cells. (A) Thio-pMacs were incubated for 2 h with pHrodo-labeled 
W3-Ildm, CDC50AED29, CDC50AED29-hCDC50A, or W3-D430G-L cells in the presence or 
absence of 4 µg/ml of D89E, and analyzed by FACS. (B) Wild-type or MerTK-/- thio-pMacs 
were incubated for 2 h with pHrodo-CDC50AED29 and analyzed by FACS. (C) pHrodo-
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CDC50AED29 was incubated with thio-pMacs in the presence of CellEventTM. Images for pHrodo 
(red), CellEvent (green), and DIC, captured every 1.5 min. Scale bar, 10 µm. Engulfment of 
CellEvent-negative (living) and -positive (dead) cells was followed for at least 130 events in 30 
fields of 3 independent experiments. The percentages of dead or living cell engulfment are at 
right. (D) Releases of engulfed CDC50AED29 (arrowhead) from thio-pMacs. Scale bar, 10 µm. 
(E) Electron transmission micrograph of thio-pMacs engulfing CDC50AED29 or FasL-treated 
W3-Ildm cells. Scale bar, 2 µm. N, macrophage nucleus. L, engulfed living cells. A, engulfed 
apoptotic cells. (F) W3-Ildm, CDC50AED29, and CDC50AED29-hCDC50A (1×106 cells) were 
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Materials and Methods 
Mice, Cell Lines, Plasmids, Recombinant Proteins, Antibodies, and Reagents 
C57BL/6J and BALB/c nude mice were purchased from Japan Clea. MerTK-/- mice (31) 
were from the Jackson Laboratory. All mouse studies were approved by the Ethics Review 
Committee for Animal Experimentation of the Graduate School of Medicine, Kyoto University.  
Human KBM7 cell line (11) was provided by Dr. Brent H. Cochran (Tufts University 
School of Medicine) and maintained in Iscove’s Modified Dulbecco’s Medium (IMDM) 
containing 10% fetal calf serum (FCS). W3 cells are transformants of  mouse T-cell lymphoma 
cells (WR19L) that express mouse (m)Fas (32), and W3-Ildm cells are WR19L cells expressing 
mFas and a caspase-resistant form of the inhibitor of caspase-activated DNase (ICAD)(17). W3 
cells, W3-Ildm cells and human Jurkat cells were cultured in RPMI1640 containing 10% FCS. 
W3-Ildm transformants expressing a constitutively active form of mTMEM16F (W3-D430G-L) 
were described previously (18). HEK293T cells were cultured in DMEM containing 10% FCS. 
For the analysis of phosphatidylserine (PtdSer) exposure, FCS was centrifuged at 100,000×g 
overnight at 4ºC, followed by filtration using 0.22-µm membranes (Millipore) to remove 
microvesicles or debris.   
The gene-trap constructs (pGT-GFP, pGT-GFP+1, and pGT-GFP+2) were described 
previously (12). The retrovirus vector pMXs-puro (33) and packaging plasmid pGag-pol-IRES-
bsr were from Dr. Toshio Kitamura (Institute of Medical Science, University of Tokyo). The 
plasmid pCMV-VSV-G was provided by Dr. Hiroyuki Miyoshi (Riken Bioresource Center, 
Riken). pAdVAntageTM, pX260, and pX330 (16) were purchased from Life Technologies 
(Invitrogen) and Addgene, respectively. Recombinant leucine-zippered human FasL (FasL) (34) 
and the D89E mutant of mMFG-E8 (19) were produced in COS7 and HEK293T cells, 
respectively, and purified. The Cy5-labeled Annexin V and fluorescein isothiocyanate (FITC)-
labeled bovine MFG-E8 (BLAC-FITC) were purchased from Biovision, and Hematologic 
Technologies, respectively. pHrodo succinimidyl ester (pHrodo) and CellEventTM Caspase-3/7 
Green were purchased from Life Technologies. 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]hexanoyl}-sn-glycero-3-phosphoserine (NBD-PS), 1-oleoyl-2-{6-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoethanolamine (NBD-PE), and 1-
oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine 
(NBD-PC) were purchased from Avanti Polar Lipids.   
Rabbit antibodies (Ab) against mATP11C were custom-prepared at the Protein Purity Co. In 
brief, a peptide, PYNDEPWYNQKTQKERET (amino acids 317-334) with an extra cysteine 
residue at the N-terminus, was conjugated to keyhole limpet hemocyanin with m-
maleimidobenzoyl-N-hydroxysuccinimide ester (Pierce), and used to immunize rabbits. The 
antibodies were affinity-purified from the serum using AF amino-Toyopearl beads (AF-Amino-
650, Tosoh Co) bound to the peptide. Rat anti-mouse Fas mAb (clone OB-22) was prepared by 
the standard protocol in our laboratory. Rabbit monoclonal antibodies (mAb) against activated 
caspase 3 (Clone 5A1E) and mouse anti-α-tubulin mAb (Clone DM1A) were from Cell 
Signaling and Calbiochem, respectively. Allophycocyanin (APC)-conjugated rat mAb against 
mouse Mac-1 (clone M1/70), and mouse anti-Green fluorescent protein (GFP) mAb (Clone JL8) 
were from BioLegend and Clontech, respectively. Horseradish peroxidase (HRP)-conjugated 




Haploid Genetic Screen 
The haploid genetic screen was performed essentially as described (12, 35). In brief, to 
produce the gene trap virus, HEK293T cells (2.4×107 cells) were co-transfected using Fugene6 
(Promega) with a mixture (36 µg) of pGT-GFP, pGT-GFP+1, and pGT-GFP+2, combined with 
8.4 µg pAdvantage, 9.0 µg pCMV-VSV-G, and 9.6 µg pGag-pol-IRES-bsr, and incubated for 48 
h. The virus in the supernatant was concentrated by centrifugation at 6,000×g for 16 h. KBM7 
cells (1×108) were seeded at 1.5×106 cells per well in 24-well culture dishes (Corning), and 
infected with the concentrated virus using spin-infection at 700×g for 45 min in the presence of 8 
µg/ml polybrene. The infected cells were expanded for 4 days and used for screening.  
The cells that lost the ability to transport aminophospholipids across the plasma membrane 
were enriched by repeating the FACS sorting twice. In brief, 6×107 mutagenized KBM7 cells 
were washed with PBS, and incubated at room temperature for 40 min with 1.5 µM NBD-PS in 
Hank’s balanced salt solution (HBSS) containing 2 mM CaCl2 and 1 mM MgCl2. The cells were 
collected by centrifugation, and suspended in HBSS containing 5 mg/ml fatty-acid-free bovine 
serum albumin (BSA) (Sigma-Aldrich) to remove NBD-PS on the cell surface. The cells were 
subjected to flow cytometry at 4°C using the FACSAria II system (BD Biosciences), and 
approximately 1% of the cells, which exhibited less efficient NBD-PS incorporation, were 
collected. The sorted cells were grown for 1-2 weeks in IMDM containing 10% FCS, and 
subjected to a second sorting as described above. The resultant cells exhibiting defective NBD-
PS incorporation were designated as Low-Flipping or LF cells. 
 
Mapping of Gene-Trap Insertion Sites  
Host sequences flanking the proviral insertion were identified by inverse polymerase chain 
reaction (PCR), followed by deep sequencing as described (12, 35). In brief, genomic DNA was 
isolated from 2×106 LF cells using the QIAamp DNA Mini Kit (Qiagen), and 4 µg DNA was 
digested with NlaIII. The digested DNA was purified using the Wizard SV Gel and PCR clean-
up column (Promega), and 1.0 µg DNA was ligated with T4 DNA ligase (Takara Bio) in a 
volume of 300 µl. The DNA was purified as above, and subjected to PCR using outward-facing 
primers complementary to the internal sequence in the gene trap vector (5’-
AATGATACGGCGACCACCGAGATCTACACATCTGATGGTTCTCTAGCTTGCC-3’ and 
5’-CAAGCAGAAGACGGCATACGAGATACCCAGGTTAAGATCAAGGTC-3’; adapter 
sequences for deep sequencing are underlined). The PCR products were purified by the Wizard 
SV Gel and PCR clean-up column, and sequenced with a primer (5’-
CTAGCTTGCCAAACCTACAGGTGGGGTCTTTCA-3’) on a MiSeq sequencer (Illumina). 
The 45-bp sequences in the FASTQ data file were mapped to the human genome (UCSC 
human genome 19; hg19) using Burrows-Wheeler Aligner software. The criteria used by Carette 
et al. (12) were applied to identify unique insertion sites. That is, the sequences carrying 
mismatches in the 45-bp sequence were removed, and if several insertions aligned 1 or 2 base 
pairs apart, only 1 was retained. The proximity index for a given insertion was defined as the 
inverse value that was calculated from the average distance between the given insertion and the 
two neighboring upstream and downstream insertions. The pipeline for the mass sequence 
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analysis was prepared as a custom-order at Amelieff Co. Forty-one insertions were found in 
CDC50A (Cell division cycle protein 50A or TMEM30A), and 86 insertions in ATP11C. 
 
Isolation of KBM7 Clones Carrying the Gene-Trap Mutations 
To obtain clonal cell lines that carried gene-trap insertions, the LF cells were subjected to 
limiting dilution. Genomic DNA was isolated from each clone using the QIAamp DNA Mini Kit, 
digested with NlaIII, and purified using the Wizard SV Gel and PCR clean-up column. The DNA 
was ligated with T4 DNA ligase, purified as above, and subjected to PCR using outward-facing 
primers complementary to the internal sequence in the gene trap vector (5’-
CTGCAGCATCGTTCTGTGTT-3’ and 5’- TCTCCAAATCTCGGTGGAAC-3’). The amplified 
PCR products were directly sequenced using a DNA sequencer (ABI PRISM 3100 Genetic 
Analyzer, Life Technologies) with the primer (5’-CTCGGTGGAACCTCCAAAT-3’). Clones 




The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas (CRISPR-
associated) system (16) was used to edit the mCDC50A and ATP11C genes in W3 and W3-Ildm 
cells. Suitable target sequences in the mCDC50A (TMEM30A) (ID: MGI 106402) and 
mATP11C (ID: MGI 1859661) genes were designed using the CRISPR Design Tool at Zhang’s 
Laboratory at UCSC (http://www.genome-engineering.org/crispr/?page_id=41). Complementary 
oligonucleotides (5’-AAACCATCGGCCTCATCTTCATCCCCATCGGCATGT-3’ and 5’-
TAAAACATGCCGATGGGGATGAAGATGAGGCCGATG-3’for CDC50A, and 5’-
CACCGTCACCAAACGGTTGAGGGTC-3’ and 5’-AAACGACCCTCAACCGTTTGGTGAC-
3’ for ATP11C, with target sequences for CDC50A and ATP11C underlined) were 
phosphorylated with T4 polynucleotide kinase (Takara Bio), heated at 95°C for 5 min, left at 
room temperature for annealing, ligated into BbsI-digested pX260 (for CDC50A) or pX330 (for 
ATP11C) vectors, and used to transform E. coli. The pX plasmid DNA carrying the targeted 
sequences was introduced into W3 or W3-Ildm cells by electroporation using a Super 
Electroporator NEPA21 type II (NepaGene). After culturing for 3 days in RPMI containing 10% 
FCS, the cells were transfected again with the pX vectors.  
To identify clones carrying mutations, the cells were subjected to limiting dilution 3 days 
after the second transfection, and the genomic DNA was prepared from individual clones using a 
QIAamp DNA Mini Kit. The DNA fragment flanking the CRISPR-target site was amplified by 
PCR using primers (CDC50A: 5’-CGTCTCCTAAAGACGCCCG-3’ and 5’- 
TCCACCCGACATTCTAGCTG-3’, and ATP11C: 5’- GCAGTGTGTTTTGTGGACGG-3’ and 
5’- CCGGGTTTCCGCTAAAACGC-3’), and directly sequenced using a DNA sequencer (ABI 
PRISM 3100 Genetic Analyzer). Gene editing at the CDC50A gene locus was observed in 6 of 
96 clones, and 2 of them (CDC50AED29 and CDC50AED62) carried biallelic changes that resulted 
in frame-shifting indels. Gene editing at the ATP11C gene locus was observed in 9 of 34 clones, 
4 of which were ATP11C-deficient clones carrying biallelic indels. Among them, 2 clones 




Rapid amplification of 5’-cDNA ends (RACE) was performed using a kit (5’-Full RACE 
Core Set; Takara Bio) according to the manufacturer's instructions. In brief, total RNA was 
prepared from KBM7 cells with the RNeasy Mini Kit (Qiagen). The first-strand cDNA was 
synthesized using AMV (Avian Myeloblastosis Virus) Reverse Transcriptase with a 5’-
phosphorylated primer (5’-CTTAGATGAGAC-3’). After degrading RNA with RNase H, the 
synthesized first-strand cDNA was ligated with T4 RNA ligase, and used as a template for nested 
PCR. Nested PCR was carried out using primers as follows (for 1st PCR; 5’-
TGGCAATCATCCAGTTTCGG-3’ and 5’-ACACTGTGCGTGTGCCAAC-3’, for 2nd PCR; 5’-
CGGAAACAGAAGCTTACATTGC-3’ and 5’-TCGTTTCTCTTCTCCAGCAC-3’). The PCR 
product was cloned in the pGEM-T easy vector, and DNA sequences were determined with a 
DNA sequencer (ABI PRISM 3100 Genetic Analyzer).  
 
Transformation of Human and Mouse Cell Lines 
The human CDC50A cDNA (NCBI: NM_018247.3) was prepared by RT-PCR with RNA 
from KBM7 cells. Since the native hATP11C cDNA (NCBI:XM_005262405.1) (36) produced 
low protein levels in mammalian cells, a sequence with enhanced mRNA stability and 
translational efficiency was custom ordered from GENEART (Regensburg, Germany). To 
generate the Mut1+2, 1+3, 2+3, or 1+2+3 mutants, hATP11C cDNA was mutated by 
recombinant PCR (37) using the following primers carrying the mutated nucleotides, with the 
sequence for the restriction enzyme site underlined. hATP11C (5’-
CATTTAATTAAGCCACCATGTTCAG-3’ and 5’-CCAGGAATTCCAGCACGTTGGACTC-





TCAAGACCAACGCCGCCGTGGCCGGCGCCACAGAG-3’. The authenticity of the cDNAs 
was confirmed by DNA sequencing.  
KBM7 cells, W3 cells, W3-Ildm cells, Jurkat cells, and their derivatives were transformed 
using a retrovirus vector carrying the Vesicular stomatitis virus (VSV)-G envelope gene. The 
cDNAs were Flag- or GFP-tagged at the C-terminus, inserted into the pMXs-puro vector, and 
introduced into HEK293T cells using Fugene 6 (Promega), together with pGag-pol-IRES-bsr, 
pCMV-VSV-G, and pAdVAntageTM. The produced retrovirus was concentrated by 
centrifugation and used to infect KBM7 cells, W3 cells, W3-Ildm cells, or Jurkat cells. The 
infected cells were cultured in the presence of puromycin at 0.8 µg/ml (for KBM7 cells) or 1 
µg/ml (for W3 cells, W3-Ildm cells or Jurkat cells).  
To examine cellular localization of ATP11C, CDC50AED29 or CDC50AED29 transformants 
expressing hCDC50A were infected by retrovirus prepared with pMXs-puro hATP11C-GFP, and 
stable transformants were selected in medium containing 1.0 µg/ml puromycin. For microscopic 
observation, the cells were grown on glass-bottom dishes (Iwaki) and observed in phenol red-
free DMEM containing 10% FCS by confocal microscopy (FV1000-D; Olympus).  
 
Induction of Apoptosis and Detection of Phosphatidylserine 
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To induce apoptosis, 1 × 106 W3-Ildm cells were treated with 33 units/ml FasL at 37°C for 
1-2 h, and the cell viability was determined by the WST-1 assay with 2-(4-Iodophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-1; Dojin 
Laboratories) and 1-Methoxy-5-methylphenazinium methylsulfate, as described (18).  
To detect PtdSer on the cell surface, cells were incubated at 25°C for 5 min with 1-2,000-
fold diluted Cy5-Annexin V or 800 ng/ml FITC-MFG-E8 in Annexin V- buffer (10 mM Hepes-
KOH (pH 7.4),140 mM NaCl, and 2.5 mM CaCl2) or IMDM supplemented with 10% FCS, 
followed by incubation with 200 nM SYTOX○R Blue (Life Technologies Molecular Probes), and 
analyzed by a FACSAria II or FACSCanto II. For microscopic observation, 2×105 cells on 8-
well Lab-Tek II chamber slides (Nalge Nunc) were incubated on ice for 15 min with 4 µg/ml 




The membrane fractions were prepared from cells expressing hATP11C-GFP or its mutants 
as described (38), and lysed in 20 mM Tris-HCl (pH 7.4), 140 mM NaCl, 1% Triton X-100, 10% 
glycerol, and 1 mM (p-aminophenyl) methanesulfonyl fluoride (APMSF). After removing 
insoluble materials by centrifugation, the membrane proteins (10 µg) were incubated at 37°C for 
1 h with 3 units of various recombinant human caspases (Biovision) in 100 µl of 50 mM Hepes-
NaOH (pH 7.4), 5% glycerol, 5 mM DTT, 10 mM EDTA, 0.1 mM APMSF and 0.1% CHAPS, 
and analyzed by Western blotting. 
 
Immunoblotting 
Cells or membrane fractions were lysed in 50 mM HEPES-NaOH (pH 8.0) buffer 
containing 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 150 mM NaCl, and a cocktail of 
protease inhibitors [cOmplete, Mini, EDTA-free, Roche Diagnostics]). After removing insoluble 
materials by centrifugation, the lysates were mixed 3:1 with 3×SDS sample buffer (200 mM 
Tris-HCl [pH 6.8], 10% SDS, 25% glycerol, 15% β-mercaptoethanol, and 0.05% bromophenol 
blue), and incubated at room temperature for 20 min. Proteins were separated by polyacrylamide 
gel electrophoresis (PAGE) in the presence of 0.1% SDS using a 7.5% or 10-20% gradient gel 
(Bio Craft), and transferred to a Polyvinylidene difluoride (PVDF) membrane (Millipore). The 
membranes were probed with mouse anti-GFP mAb, rabbit anti-active caspase-3 mAb, rabbit 
anti-hATP11C Ab, rabbit anti-α-tubulin mAb, or rat anti-mFas mAb, followed by incubation 
with HRP-conjugated goat anti-mouse Igs, goat anti-rabbit Igs or rabbit anti-rat Igs. The 
peroxidase activity was detected by the Western Lightning-ECL system (PerkinElmer).  
 
In vitro Phagocytosis Assay 
To prepare thioglycollate-elicited peritoneal macrophages (thio-pMacs), female C57BL/6J 
mice at 7-12 weeks of age were injected intraperitoneally with 60 mg of thioglycollate (Sigma-
Aldrich), and peritoneal macrophages were collected 4 days later. Phagocytosis was assayed by 
following the transport of pHrodo-stained prey into macrophage lysosomes (39, 40). In brief, 
5×105 thio-pMacs were grown overnight in 12-well plates (Corning). Growing or apoptotic cells 
(2.0×107) were washed with PBS and incubated with 40 ng/ml pHrodo for 10 min at room 
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temperature. After stopping the reaction with 2 ml FCS, the cells were washed with IMDM 
containing 10% FCS, added to the macrophages in the medium containing 1% methyl cellulose 
(Sigma-Aldrich), spun at 500×g for 4 min at room temperature using a swinging rotor, and 
incubated at 37°C. The macrophages were detached from the plate by treatment with 0.25% 
trypsin, stained with APC-conjugated rat anti-mouse Mac1, suspended in 20 mM CHES-NaOH 
buffer (pH 9.0) containing 150 mM NaCl, 2% FCS, and 200 nM Sytox blue, and analyzed by 
flow cytometry using the FACSCanto II. Phagocytosis was defined as the percentage of pHrodo-
positive cells in the Mac-1+ Sytox blue- population.  
For time-lapse observation, thio-pMacs (5×104) were grown overnight in eight-well Lab-
Tek II chambers coated with fibronectin. The pHrodo-labeled cells (2 ×105) in IMDM containing 
10% FCS, 1% methylcellulose and 5 µM CellEventTM Caspase-3/7 Green were added to the 
macrophages, and the mixture was spun at 500×g for 4 min at room temperature. The cell culture 
was followed for 3-4 h in real time using a confocal microscope (FV1000-D), and images were 
captured every 1-2 min.   
 
Electron Microscopy 
Mouse thio-pMacs were incubated for 2 h with prey in IMDM containing 10% FCS and 1% 
methylcellulose as described above. Macrophages were then detached from the plate by scraping, 
and fixed by incubation at 4°C overnight in PBS containing 4% paraformaldehyde and 2% 
glutaraldehyde (Nacalai Tesque). After washing with 0.1 M phosphate buffer 3 times, the 
samples were post-fixed with at 4°C for 2 h with 1% OsO4 in 0.1 M phosphate buffer, and 
dehydrated by successive incubations in serially diluted ethanol (50, 60, 70, 80, 90, and 99% 
ethanol) for 20 min each, followed by dipping into 100% ethanol for 30 min twice. The samples 
were successively incubated twice in propylene oxide for 1 h, in a 1:1 mixture of propylene 
oxide and epoxide (Luveak 812, Nacalai Tesque) for 1.5 h, in a 1:3 mixture of propylene oxide 
and epoxide for 1.5 h, and in epoxide for 12 h. They were then embedded in epoxide by 
incubating at 60°C for 3 days. Ultrathin sections (60-80 nm) were cut with an ultramicrotome 
EM UC6 (Leica), stained with uranyl acetate and lead citrate, and observed with an electron 
microscope H-7650 (Hitachi). 
 
Internalization of NBD Lipids. 
Cells (2×106) were incubated with 1.5 µM NBD-PS, NBD-PE, or NBD-PC at 25°C for 5 
min in 600 µl of HBSS containing 1 mM MgCl2 and 2.5 mM CaCl2. After incubation, the cells 
were collected by centrifugation, resuspended in HBSS containing 5 mg/ml fatty-acid-free BSA, 
and analyzed by a FACSAria II. To determine the scramblase activity, 1.5×106 cells were 
incubated at 25°C for 4 min with 0.5 µM NBD-PC.  
 
Tumor Development 
To develop tumor in nude mice, 1 × 106 cells were subcutaneously injected into 7-week-old 
female BALB/c athymic nude mice. Four weeks later, the tumors were dissected and weighed. 
 
Reverse Transcription (RT)-PCR 
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Total RNA was prepared with Isogen (Nippon Gene), followed by the RNeasy Mini Kit 
(Qiagen), and was reverse-transcribed with a High Capacity RNA-to-cDNATM Kit (Life 
Technologies, Applied Biosystems). The cDNA was amplified using LightCycler 480 SYBR 
Green I Master (Roche Diagnostics). Primers for real-time RT-PCR were:  
hCDC50A, 5’-CGATGGCGATGAACTATAACGC-3’ and 5’-
CGGTATAATCAATCTCGATCTC-3’; hATP11C, 5’-GGAACGTAATGCAATGGATGGG-3’ 
and 5’-GGTTAGTTCTAAGAGCTCAGTG-3’; hβ-actin, 5’-GCATCCTCACCCTGAAGTAC-
3’ and 5’-CTTAATGTCACGCACGATTTC-3’;  
mCDC50A, 5’-TGCCAACAGCATGTTTAATGA-3’ and 5’- 
TTCGAGGCTCTCTTTTCCAG-3’; mCDC50B, 5’-AACGACTCCTTCTCGCTCTG-3’  and 5’-
CACGAAGTCCTGGTTGATGA-3’; mCDC50C, 5’-TTTCGGAATCCAAGATCCAG-3’ and 
5’-CAGTCGGCGGTACAGTTTTT-3’; mATP8A1, 5’-TGTGTGCTTGAAAGCTGGAC-3’ and 
5’-CACCCAGAAGACTCCAGAGC-3’; mATP8A2, 5’-ATTGTTCCTGGTTCCGACTG-3’ and 
5’-GGAGGTGTCTTCCTGCTGAG-3’; mATP8B1, 5’-TGCCGTGTGCTTACTACCTG-3’ and 
5’-GGAGATGAGGTCTGCGTAGC-3’; mATP8B2, 5’-CAGGCCAGTTGAACCTCCTA-3’ 
and 5’-GCACACTGACCACAATGACC-3’; mATP8B3, 5’-TGTACTCAATGTGGCCCTGA-3’ 
and 5’-GAGAAGGCATAGCTGGAACG-3’; mATP8B4, 5’-CTCCCTGAGCCAGAAGTTTG-
3’ and 5’-GTGATGAGCTCTCCGTAGCC-3’; mATP8B5, 5’-TCCAGTCCTTCTCCCTGCTA-
3’ and 5’-GGCCACACCTAGGAAATTGA-3’; mATP9A, 5’-ACGATGTTTCCCGTGTTCTC-
3’ and 5’-GAAGGAGATTGCCACGATGT-3’; mATP9B, 5’-CGAGTTTGTCCATGTTGTGG-
3’ and 5’-GAAAGCGCCAAAAGACACTC-3’; mATP10A, 5’-
ACCCTTACTGGACCATGCAG-3’ and 5’- GCTGTCCCTGAGCAAAAGTC-3’; mATP10B, 
5’- GTGATGGAAAGGCAGCTCTC-3’ and 5’-AGGCAGAAGCAGAAGCAGAG-3’; 
mATP10D, 5’-CCGTGTTTCCATCTCCAGTT-3’ and 5’- CAGAAGACCCAGGTGTTGGT-3’; 
mATP11A, 5’- CTGGCGGGTGTTCATTTACT-3’ and 5’-TGACAGTGAGCACCATCACA-
3’; mATP11B,5’-TTTTGGGCTCCCAGAATATG-3’ and 5’- TTCTTCCAACAGACGCACAC-
3’; mATP11C, 5’-TTACAGTTGGGGCCCTTCTT-3’and 5’-TATCCAAGGCGAGCTTCAGA-
3’; mβ-actin, 5’-TGTGATGGTGGGAATGGGTCAG-3’ and 5’-
TTTGATGTCACGCACGATTTCC-3’.  
The RT-PCR analysis for P4-ATPase and CDC50 family members in KBM7 cells was 
carried out with specific primers described by Takatsu et al (13). 
 
Statistical Analysis 
All data were expressed as the mean with S.D. The statistical significance of the differences 







Fig. S1: The transcription initiation site for hATP11C determined by 5’-RACE-PCR. 
(A) The cDNA encompassing the 5’-region of hATP11C mRNA was prepared by reverse-
transcribing mRNA with a phosphorylated primer in exon 2. The cDNA was then ligated, and 
used as a template for the nested PCR. Primers used for the nested PCR (1st and 2nd PCR) are 
indicated by arrows. (B) 5’-RACE-PCR products. (C) Sequence at the 5’ end of hATP11C 
determined by 5’-RACE-PCR. The 400-bp DNA fragment in (B) was cloned into the pGEM-T 
easy vector, and the DNA sequence was determined. The putative transcription initiation sites 




Fig. S2: Structure and expression of ATP11C and CDC50A. 
(A) The structures of hATP11C and hCDC50A with transmembrane segments numbered. In 
hATP11C, three cytoplasmic domains (A: actuator, P: phosphorylation, and N: nucleotide 
binding) predicted by similarity to SERCA2a (41) are shown in green circles. (B) ATP11C and 
CDC50A mRNA levels in the indicated mouse tissues were determined by real-time RT-PCR, 
and expressed as copy numbers per ng of total RNA. (C) Real-time RT-PCR for ATP11C and 
CDC50A mRNAs relative to β-actin mRNA in KBM7 (Parental), ATP11CGT, and CDC50AGT. 






Fig. S3: Effect of ATP11C deficiency on phospholipid incorporation.  
(A) Expression of P4-type ATPase in mouse W3 cells. The mRNA level for the indicated P4-
type ATPases was determined by Real-Time RT-PCR, and is expressed to relative to β-actin 
mRNA. (B) W3 cells were incubated with 1.5 µM NBD-PS (PtdSer), NBD-PE (PtdEtn), or 
NBD-PC (PtdCho), treated with fatty-acid-free BSA, and analyzed by flow cytometry. The mean 
fluorescent intensity (MFI) is plotted. (C) Mutagenesis of mATP11C gene in W3 cells by 
CRISPR-Cas system. Protospacer sequence is highlighted in light blue, protospacer-adjacent 
motif (PAM) underlined in red, and the cleavage site with red arrowhead. The targeted ATP11C 
in ATP11CED22 and ATP11CED23, carrying a biallelic insertion of “GT” or “A” (in red). (D) The 
reduced incorporation of PtdEtn in ATP11C mutants. ATP11CED mutants (ATP11CED22 and 
ATP11CED23), and ATP11CED22 cells expressing hATP11C were incubated at room temperature 
for 5 min with 1.5 µM NBD-PE (PtdEtn). The cells were treated with fatty-acid-free BSA, and 
analyzed by flow cytometry. The incorporated NBD-PE is expressed as ratio of that with W3 





Fig. S4: The structure of ATP11C and its caspase-recognition site mutants. 
(A) The structure of hATP11C-GFP with caspase-recognition sites and α-helix boxed in red and 
black. The transmembrane region is numbered. The amino acid positions of the caspase-
recognition site are indicated with the wild-type and mutated sequence. GFP, Green fluorescent 
protein. In the lower part, sequences around the caspase-recognition sites in 6 vertebrate 
ATP11C are aligned with * for residues conserved in all members. The caspase recognition sites 
were numbered as Site 1-3 from the N-terminus. (B) Schematic representation of human 
ATP11C caspase-recognition site mutants. At top, the three caspase-recognition sites (red boxes) 
located in the second cytoplasmic loop between transmembrane segments 4 and 5 (blue boxes) of 
hATP11C are schematically shown. In the indicated mutants, the aspartic acid residues in the 
caspase-recognition sites (Sites 1-3) were mutated to alanine residues. In the Mut 1+2, 1+3, and 
2+3 mutants, 2 caspase-recognition sites were mutated in different combinations, while all 3 
recognition sites were mutated in the Mut 1+2+3 mutant (CasR). 
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Fig. S5:  Cleavage of ATP11C by caspases. 
Solubilized membrane fractions of ATP11CED22 transformants expressing wild-type (upper 
panel) or mutant (lower panel) ATP11C-GFP were incubated with caspases (C1 to C10, caspase-




Fig. S6:  Effect of the caspase-resistant ATP11C on the apoptotic PtdSer exposure. 
W3-Ildm (A) and Jurkat (B) were transformed with hATP11C or CasR (W3-hATP11C, W3-
CasR, Jurkat-hATP11C, and Jurkat-CasR), treated with FasL for 2 h, stained with Annexin V, 
and analyzed by FACS. At bottom, cell lysates were analyzed by Western blotting with anti-
active caspase-3 or anti-tubulin. 
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Fig. S7:  No effect of the caspase-resistant hATP11C on FasL-induced cell death, DNA 
fragmentation, or cell shrinkage. 
W3, ATP11CED22, or ATP11CED22 transformants expressing hATP11C or its caspase-resistant 
form (CasR) were incubated with FasL for 2 h. (A) FasL-induced cell death was analyzed with 
the WST-1 assay. (B) Chromosomal DNA was prepared from untreated or FasL-treated cells, 
separated by electrophoresis on a 1.5 % agarose gel, and stained with ethidium bromide. (C) 
Untreated or FasL-treated cells were analyzed by flow cytometry. The forward scatter (FSC) 




Fig. S8:  Mutagenesis of CDC50A gene in W3-Ildm cells. 
(A) Expression of CDC50 family members in mouse W3-Ildm cells. The mRNA level of 
mCDC50 member (50A, 50B and 50C) was determined by Real-Time RT-PCR, and is expressed 
relative to β-actin mRNA. (B) Mutagenesis of mCDC50A gene by CRISPR-Cas system. 
Protospacer sequence is highlighted in light blue, protospacer-adjacent motif (PAM) underlined 
in red, and red arrowhead for the cleavage site. Two mutated cell clones (CDC50AED29 and 
CDC50AED62) carry different indels (in red) in two alleles, causing truncation of the protein at 
positions 76 and 99, and 76 and 77, respectively. 
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Fig. S9: PtdSer exposure in CDC50A-deficient viable cells. 
(A) W3-Ildm, CDC50AED29, or CDC50AED62 cells were treated with or without FasL for 2 h, 
stained with Cy5-labeled Annexin V and Sytox blue, and analyzed by flow cytometry. (B) W3-
Ildm, CDC50AED29, CDC50AED62, or their transformants expressing hCDC50A were seeded at 
104 cells/ml in RPMI containing 10% FCS, and cultured. The cells were split every 3 days, and 
re-seeded at 104 cells/ml, and their growth was followed for 9 days. (C) W3-Ildm, CDC50AED29, 
CDC50AED62, or their transformants expressing hCDC50A were incubated with the indicated 
concentration of FasL for 4 h at 37 ºC. The cell viability was determined with the WST-1 assay, 
and is expressed as the percentage of cell viability in the absence of FasL. 
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Fig. S10:  Thio-pMac engulfment of PtdSer-exposing human KBM7 cells. 
Thio-pMacs were incubated with pHrodo-labeled KBM7 in the presence of CellEventTM caspase 





Movie S1: Engulfment of Living CDC50A-/- Cells by Macrophage. 
At the beginning, a macrophage at right side engulfs two pHrodo-labeled (pale red) and 
CellEvent-negative CDC50A-/- cells, then the pHrodo-fluorescence of the engulfed cells 
increases, indicating that the cells were transferred to lysosomes. Then, another macrophage at 
left side engulfs one CellEvent-negative cell. 
 
Movie S2: Engulfment of Dead CDC50A-/- Cells by Macrophage. 
A pHrodo-labeled (pale red) and CellEvent-positive (green) apoptotic CDC50A-/- cell moves 
above a macrophage, and is engulfed. The pHrodo-fluorescence of the engulfed cells then 
increases, and the cell gets yellow. 
 
Movie S3: Release of Living CDC50A-/- Cells from Macrophage. 
A macrophage at the center engulfs a pHrodo-labeled (pale red) and CellEvent-negative 
CDC50A-/- cell. The intensity of pHrodo fluorescence of the engulfed cells gradually increases, 
but suddenly the cell is released from the macrophage before transferring to lysosomes (or 
increasing its pHrodo-fluorescence).  
 
 
 
